Jace Investments Inc. Dba Oncology Convergence Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Jace Investments Inc. Dba Oncology Convergence

Access the complete profile.

Jace Investments Inc. Dba Oncology Convergence Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	52391 Venture Capital, Multifamily Investment Firms & Other Intermediation
Address	2305 East Arapahoe Road, Suite 113 Centennial, CO 80122

Note: Revenues for privately held companies are statistical evaluations.


Jace Investments Inc. Dba Oncology Convergence's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Jace Investments Inc. Dba Oncology Convergence's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Jace Investments Inc. Dba Oncology Convergence is classified as operating in the Venture Capital, Multifamily Investment Firms & Other Intermediation industry, NAICS Code 52391.

Jace Investments Inc. Dba Oncology Convergence Annual Revenue and Growth Rate

Jace Investments Inc. Dba Oncology Convergence	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Jace Investments Inc. Dba Oncology Convergence's revenues are gauged from an analysis of company filings.

Jace Investments Inc. Dba Oncology Convergence's Income Statement (based on Industry Averages)

Jace Investments Inc. Dba Oncology Convergence P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Jace Investments Inc. Dba Oncology Convergence's Largest Competitors

A competitive analysis shows these companies are in the same general field as Jace Investments Inc. Dba Oncology Convergence, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
J&P INVESTMENTS	Phoenix, AZ	100
RMH FRANCHISE	Atlanta, GA	100
KINGMAN INVESTMENTS	Kingman, AZ	92
EFFORTLESS INVESTMENTS MGT.	Rolling Hills, CA	82
SP ACQUISITION IL	Niles, IL	81
CROWN CAPITAL STAFFING STRATEGIES	Bloomington, MN	78
GRECO INVESTMENTS VI	Gunnison, CO	64
AJS ACQUISITIONS	Warren, NJ	57
MELON INVESTMENTS	Saint Paul, MN	50

Nearby Competitors

These companies are similar in business line and location to Jace Investments Inc. Dba Oncology Convergence. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PRIME INVESTMENT	Castle Rock, CO	100
JACE INVESTMENTS INC. DBA ONCOLOGY CONVERGENCE	Centennial, CO	75
RFC DRILLING	Greenwood Village, CO	75
VUKOTA CAPITAL MANAGEMENT	Greenwood Village, CO	32
LORD & RICHARDS	Highlands Ranch, CO	17

Future Competition: Jace Investments Inc. Dba Oncology Convergence's Fastest Growing Competitors

These companies are in the same general field as Jace Investments Inc. Dba Oncology Convergence and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)